179,700.00
-500.00
(-0.28%)
At close: January 31 at 3:30:25 PM GMT+9
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
19,917,534,297.16
5,891,652,311.25
5,674,122,532.47
5,020,121,254.00
Total Liabilities Net Minority Interest
2,791,739,989.93
1,617,448,041.46
1,623,747,845.67
1,592,540,899.88
Total Equity Gross Minority Interest
17,125,794,307.23
4,274,204,269.78
4,050,374,686.79
3,427,580,354.00
Total Capitalization
17,079,816,722.96
4,290,939,926.76
4,087,620,931.24
3,507,546,921.00
Common Stock Equity
16,980,683,406.96
4,139,360,000.76
3,917,237,794.24
3,307,677,045.00
Capital Lease Obligations
16,153,222.00
5,616,153.00
7,384,189.00
5,512,344.00
Net Tangible Assets
3,644,566,188.96
2,517,033,756.76
2,425,666,820.24
1,903,488,459.00
Working Capital
2,538,778,596.31
1,635,694,727.27
1,863,990,949.53
1,459,727,991.20
Invested Capital
18,854,950,387.96
4,926,075,771.76
4,654,209,305.24
4,076,567,649.00
Tangible Book Value
3,644,566,188.96
2,517,033,756.76
2,425,666,820.24
1,903,488,459.00
Total Debt
1,890,420,203.00
792,331,924.00
744,355,700.00
774,402,948.00
Net Debt
1,309,655,261.44
235,529,101.19
--
84,596,716.60
Share Issued
220,175.76
140,398.83
143,465.01
143,205.67
Ordinary Shares Number
207,207.53
137,792.71
142,088.96
141,919.01
Treasury Shares Number
13,082.99
3,012.50
1,376.06
1,286.66
12/31/2020 - 7/19/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
298380.KQ ABL Bio Inc.
36,350.00
+2.97%
310210.KQ Voronoi, Inc.
86,100.00
+7.22%
326030.KS SK Biopharmaceuticals Co., Ltd.
109,100.00
-0.09%
196170.KQ ALTEOGEN Inc.
371,500.00
+2.62%
207940.KS Samsung Biologics Co.,Ltd.
1,081,000.00
-0.55%
XNCR Xencor, Inc.
18.28
-1.19%
ORIC ORIC Pharmaceuticals, Inc.
10.42
-3.25%
GLPG Galapagos NV
23.00
-0.04%
RANI Rani Therapeutics Holdings, Inc.
1.3900
+0.72%
VYGR Voyager Therapeutics, Inc.
5.45
-2.85%